Literature DB >> 10504695

Tumor angiogenesis--new drugs on the block.

V Brower.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10504695     DOI： 10.1038/13654

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  13 in total

Review 1.  The role of angiogenesis in rheumatoid arthritis: recent developments.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

2.  TTD: Therapeutic Target Database.

Authors:  X Chen; Z L Ji; Y Z Chen
Journal:  Nucleic Acids Res       Date:  2002-01-01       Impact factor: 16.971

Review 3.  Anti-angiogenic treatment strategies for malignant brain tumors.

Authors:  M Kirsch; G Schackert; P M Black
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

4.  Isolation of anti-angiogenesis antibodies from a large combinatorial repertoire by colony filter screening.

Authors:  L Giovannoni; F Viti; L Zardi; D Neri
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

5.  Antitumor activity of cytotoxic T lymphocytes engineered to target vascular endothelial growth factor receptors.

Authors:  Thomas M J Niederman; Zoher Ghogawala; Bob S Carter; Hillary S Tompkins; Margaret M Russell; Richard C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

6.  Therapeutic efficacy of a synthetic epsin mimetic peptide in glioma tumor model: uncovering multiple mechanisms beyond the VEGF-associated tumor angiogenesis.

Authors:  Jerry Dong; Debra Saunders; Robert Silasi-Mansat; Lili Yu; Hua Zhu; Florea Lupu; Rheal Towner; Yunzhou Dong; Hong Chen
Journal:  J Neurooncol       Date:  2018-01-22       Impact factor: 4.130

7.  Polyacetylenes function as anti-angiogenic agents.

Authors:  Li-Wha Wu; Yi-Ming Chiang; Hsiao-Ching Chuang; Sheng-Yang Wang; Ga-Wen Yang; Ya-huey Chen; Ling-Ya Lai; Lie-Fen Shyur
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

8.  Motif mimetic of epsin perturbs tumor growth and metastasis.

Authors:  Yunzhou Dong; Hao Wu; H N Ashiqur Rahman; Yanjun Liu; Satish Pasula; Kandice L Tessneer; Xiaofeng Cai; Xiaolei Liu; Baojun Chang; John McManus; Scott Hahn; Jiali Dong; Megan L Brophy; Lili Yu; Kai Song; Robert Silasi-Mansat; Debra Saunders; Charity Njoku; Hoogeun Song; Padmaja Mehta-D'Souza; Rheal Towner; Florea Lupu; Rodger P McEver; Lijun Xia; Derek Boerboom; R Sathish Srinivasan; Hong Chen
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

9.  (64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity.

Authors:  Lihui Wei; Yunpeng Ye; Thaddeus J Wadas; Jason S Lewis; Michael J Welch; Samuel Achilefu; Carolyn J Anderson
Journal:  Nucl Med Biol       Date:  2009-04       Impact factor: 2.408

10.  Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.

Authors:  Lijun Wang; Jiyun Shi; Young-Seung Kim; Shizhen Zhai; Bing Jia; Huiyun Zhao; Zhaofei Liu; Fan Wang; Xiaoyuan Chen; Shuang Liu
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.